Literature DB >> 20947053

Myocardial perfusion imaging in hypertrophic cardiomyopathy.

Vasken Dilsizian1, Julio A Panza, Robert O Bonow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947053     DOI: 10.1016/j.jcmg.2010.07.013

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


× No keyword cloud information.
  4 in total

Review 1.  Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.

Authors:  Vasken Dilsizian; Henry Gewirtz; Nicholas Paivanas; Anastasia N Kitsiou; Fadi G Hage; Nathan E Crone; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

Review 2.  Microvascular Angina Diagnosed by Absolute PET Myocardial Blood Flow Quantification.

Authors:  Matthieu Pelletier-Galarneau; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2020-01-28       Impact factor: 2.931

3.  Relative Prognostic Significance of Positron Emission Tomography Myocardial Perfusion Imaging Markers in Cardiomyopathy.

Authors:  Merrill Thomas; Brett W Sperry; Poghni Peri-Okonny; Ali O Malik; A Iain McGhie; Ibrahim M Saeed; Paul S Chan; John A Spertus; Randall C Thompson; Timothy M Bateman; Krishna K Patel
Journal:  Circ Cardiovasc Imaging       Date:  2021-10-19       Impact factor: 8.589

Review 4.  The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update.

Authors:  Partho P Sengupta; Christopher M Kramer; Jagat Narula; Vasken Dilsizian
Journal:  JACC Cardiovasc Imaging       Date:  2017-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.